BIBR1532 | Telomerase inhibitor
Available Options
| Size | Price | Quantity | |
|---|---|---|---|
| 5mg | $60.00 | ||
| 25mg | $195.00 |
BIBR1532 (321674-73-1) is a non-competitive specific inhibitor of telomerase (IC50 = 93 nM), targeting telomerase reverse transcriptase (hTERT).1,2 Induces apoptosis in MCF-7 breast cancer cells and breast cancer stem cells3 and affected the epithelial mesenchymal transition in breast cancer stem cells4. BIBR1532 eliminated pancreatic stem cells via DNA damage and apoptosis in primary patient-derived samples.5 It significantly inhibited cell proliferation and induced apoptosis in acute myeloid leukemia stem cells.6
References/Citations:
- Damm et al. (2001), A highly selective telomerase inhibitor limiting human cancer cell proliferation; EMBO J., 20 6958
- Pascolo et al. (2002), Mechanism of human telomerase inhibition by BIBR1532, a synthetic, non-nucleosidic drug candidate; J. Biol. Chem., 277 15566
- Dogan et al. (2018), Investigation of the effect of telomerase inhibitor BIBR1532 on breast cancer and breast cancer stem cells; J. Cell Biochem., 120 1282
- Kusoglu et al. (2020), Telomerase inhibition regulates EMT mechanism in breast cancer stem cells; Gene, 759 145001
- Walter et al. (2021), Telomerase and Pluripotency Factors Jointly Regulate Stemness n Pancreatic Cancer Stem Cells; Cancers (Basel), 13 3145
- Rafat et al. (2022), Telomerase inhibition on acute myeloid leukemia stem cell induced apoptosis with both intrinsic and extrinsic pathways; Life Sci., 295 120402
C21H17NO3
>98% HPLC
NMR (Conforms)
Safety Data Sheet:
Product Data Sheet:
Materials provided by Focus Biomolecules are for laboratory research use only and are not intended for human or veterinary applications. Please note that we do not sell to individuals and that all orders placed by non-research organizations will incur a $20 restocking/refund fee
BIBR1532 (321674-73-1) is a non-competitive specific inhibitor of telomerase (IC50 = 93 nM), targeting telomerase reverse transcriptase (hTERT).1,2 Induces apoptosis in MCF-7 breast cancer cells and breast cancer stem cells3 and affected the epithelial mesenchymal transition in breast cancer stem cells4. BIBR1532 eliminated pancreatic stem cells via DNA damage and apoptosis in primary patient-derived samples.5 It significantly inhibited cell proliferation and induced apoptosis in acute myeloid leukemia stem cells.6
References/Citations:
- Damm et al. (2001), A highly selective telomerase inhibitor limiting human cancer cell proliferation; EMBO J., 20 6958
- Pascolo et al. (2002), Mechanism of human telomerase inhibition by BIBR1532, a synthetic, non-nucleosidic drug candidate; J. Biol. Chem., 277 15566
- Dogan et al. (2018), Investigation of the effect of telomerase inhibitor BIBR1532 on breast cancer and breast cancer stem cells; J. Cell Biochem., 120 1282
- Kusoglu et al. (2020), Telomerase inhibition regulates EMT mechanism in breast cancer stem cells; Gene, 759 145001
- Walter et al. (2021), Telomerase and Pluripotency Factors Jointly Regulate Stemness n Pancreatic Cancer Stem Cells; Cancers (Basel), 13 3145
- Rafat et al. (2022), Telomerase inhibition on acute myeloid leukemia stem cell induced apoptosis with both intrinsic and extrinsic pathways; Life Sci., 295 120402
Related products
-
Imiquimod | TLR7 Agonist
From $30.00CAS:99011-02-6Catalog Number:10-4230Alternate Name:R837Activity:TLR7 agonistChemical Name:1-(2-Methylpropyl)imidazo[4,5-c]quinolin-4-amineMolecular Weight:240.30Molecular Formula:C14H16N4Solubility:Soluble in DMSO (2 mg/ml with warming)Physical Properties:White solidPurity:>98% by TLC
NMR (Conforms)Storage Temperature:-20°CStability:Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 3 months.Shipping Code:RT -
Rucaparib phosphate | PARP1 inhibitor
From $70.00CAS:459868-92-9Catalog Number:10-3321Activity:PARP1 inhibitorChemical Name:8-Fluoro-1,3,4,5-tetrahydro-2-[4-[(methylamino)methyl]phenyl]-6H-pyrrolo[4,3,2-ef][2]benzazepin-6-oneAlternate Name:AG-14699; PF01367338Molecular Weight:421.36Molecular Formula:C19H18FN3O • H3PO4Solubility:Soluble in DMSO (up to 25 mg/ml).Physical Properties:Yellow solidPurity:98% by HPLC
NMR (Conforms)Storage Temperature:-20°Stability:Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20° for up to 3 months.Shipping Code:RT -
SNS-314 mesylate | Aurora kinase inhibitor
From $70.00CAS:1146618-41-8Catalog Number:10-4779Activity:Aurora kinase inhibitorChemical Name:1-(3-Chlorophenyl)-3-[5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl]urea mesylateMolecular Weight:527.04Molecular Formula:C18H15ClN6OS2 • CH3SO3HSolubility:Soluble in DMSO (up to at least 25 mg/ml).Physical Properties:Off-white solidPurity:98% by HPLC
NMR (Conforms)Storage Temperature:-20°Stability:Stable for 1 year as supplied. Solutions in DMSO may be stored at -20° for up to 1 month.Shipping Code:RT
Calculate the molar concentration, mass or volume in a solution.
Concentration × Volume × Molecular Weight = Mass
